Utilização de glifosato para o controle de ferrugem da soja

O objetivo deste trabalho foi avaliar o efeito de glifosato sobre a germinação de esporos de Phakopsora pachyrhizi e no controle da ferrugem da soja, aplicado preventiva e erradicativamente, em condições controladas. A germinação de esporos foi avaliada tendo-se vertido, em meio de cultura, soluções de esporos com diferentes concentrações do glifosato (0, 100, 1.000, 10.000 e 20.000 ppm) e fungicidas. Para avaliar o controle da ferrugem, plantas foram pulverizadas com glifosato, com variação da dose e do momento, tendo-se medido a severidade da doença. Houve efeito do produto sobre os esporos do fungo, o que reduziu sua germinação. As pulverizações em plantas, em casa de vegetação, mostraram um efeito do produto sobre a ferrugem, quando aplicado preventivamente, porém com período de proteção curto e fungitoxicidade inferior à do fungicida tebuconazole. O uso do glifosato, avaliado nesse ensaio, não deve ser visto como medida de manejo de ferrugem, e não interfere nas práticas habituais de controle da ferrugem da soja.

A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.

The comparison of radiotherapy techniques regarding secondary cancer risk has yielded contradictory results possibly stemming from the many different approaches used to estimate risk. The purpose of this study was to make a comprehensive evaluation of different available risk models applied to detailed whole-body dose distributions computed by Monte Carlo for various breast radiotherapy techniques including conventional open tangents, 3D conformal wedged tangents and hybrid intensity modulated radiation therapy (IMRT). First, organ-specific linear risk models developed by the International Commission on Radiological Protection (ICRP) and the Biological Effects of Ionizing Radiation (BEIR) VII committee were applied to mean doses for remote organs only and all solid organs. Then, different general non-linear risk models were applied to the whole body dose distribution. Finally, organ-specific non-linear risk models for the lung and breast were used to assess the secondary cancer risk for these two specific organs. A total of 32 different calculated absolute risks resulted in a broad range of values (between 0.1% and 48.5%) underlying the large uncertainties in absolute risk calculation. The ratio of risk between two techniques has often been proposed as a more robust assessment of risk than the absolute risk. We found that the ratio of risk between two techniques could also vary substantially considering the different approaches to risk estimation. Sometimes the ratio of risk between two techniques would range between values smaller and larger than one, which then translates into inconsistent results on the potential higher risk of one technique compared to another. We found however that the hybrid IMRT technique resulted in a systematic reduction of risk compared to the other techniques investigated even though the magnitude of this reduction varied substantially with the different approaches investigated. Based on the epidemiological data available, a reasonable approach to risk estimation would be to use organ-specific non-linear risk models applied to the dose distributions of organs within or near the treatment fields (lungs and contralateral breast in the case of breast radiotherapy) as the majority of radiation-induced secondary cancers are found in the beam-bordering regions.

Desempenho de genótipos de milho cultivados com diferentes quantidades de palha de aveia-preta e doses de nitrogênio

O objetivo deste trabalho foi avaliar a resposta de genótipos de milho (Zea mays L.), cultivado em sistema de plantio direto, a diferentes quantidades de palha de aveia-preta (Avena strigosa Schreb.) e doses de nitrogênio. O experimento foi conduzido em um Latossolo Vermelho eutrófico, em delineamento experimental de blocos ao acaso em parcelas subsubdivididas, com três repetições. As parcelas principais foram representadas pelas quantidades de palha na superfície do solo (sem palha, 5,16 e 10,32 mg ha-1). As subparcelas foram representadas por três genótipos de milho e as subsubparcelas constituíram-se das doses 0, 60, 120, 180 e 240kg ha-1 de nitrogênio. O aumento da dose de nitrogênio reduziu a requeima das folhas e promoveu o suprimento adequado de nitrogênio das plantas de milho em todos os tratamentos com palha de aveia-preta. Os genótipos de milho diferenciaram-se quanto à produtividade de grãos, ao aproveitamento do nitrogênio mineralizado da palha e ao comprimento do sistema radicular, quando submetidos a diferentes quantidades de palha de aveia-preta e de nitrogênio.

Controle genético do comprimento do pedúnculo em feijão-caupi

O objetivo deste trabalho foi estudar o controle genético do caráter comprimento do pedúnculo em feijão-caupi (Vigna unguiculata). Para isso, foi realizado um cruzamento entre os parentais TVx-5058-09C, de pedúnculo curto, e TE96-282-22G, de pedúnculo longo. Os parentais e as gerações F1, F2, RC1 (P1xF1) e RC2 (P2xF1) foram avaliados em delineamento de blocos ao acaso, com quatro repetições. Foram estimados: variâncias fenotípica, genotípica, ambiental, aditiva e de dominância; herdabilidades no sentido amplo e restrito; grau médio de dominância e número mínimo de genes que determinam o caráter. O modelo aditivo-dominante foi adequado para explicar a variação observada. O efeito gênico aditivo foi o mais importante no controle do comprimento do pedúnculo, que é, aparentemente, controlado por cinco genes.

Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study.

Background We previously reported the results of a phase II study for patients with newly diagnosed primary central nervous system lymphoma treated with autologous peripheral blood stem-cell transplantation (aPBSCT) and response-adapted whole-brain radiotherapy (WBRT). Now, we update the initial results. Patients and methods From 1999 to 2004, 23 patients received high-dose methotrexate. In case of at least partial remission, high-dose busulfan/thiotepa (HD-BuTT) followed by aPBSCT was carried out. Patients refractory to induction or without complete remission after HD-BuTT received WBRT. Eight patients still alive in 2011 were contacted and Mini-Mental State Examination (MMSE) and the European Organisation for Research and Treatment of Cancer quality-of-life questionnaire (QLQ)-C30 were carried out. Results Of eight patients still alive, median follow-up is 116.9 months. Only one of nine irradiated patients is still alive with a severe neurologic deficit. In seven of eight patients treated with HD-BuTT, health condition and quality of life are excellent. MMSE and QLQ-C30 showed remarkably good results in patients who did not receive WBRT. All of them have a Karnofsky score of 90%-100%. Conclusions Follow-up shows an overall survival of 35%. In six of seven patients where WBRT could be avoided, no long-term neurotoxicity has been observed and all patients have an excellent quality of life.

Eficácia e pH de caldas de glifosato após a adição de fertilizantes nitrogenados e utilização de pulverizador pressurizado por CO2

Este trabalho foi desenvolvido com o objetivo de avaliar a eficácia e o pH de caldas de glifosato após a adição de fertilizantes nitrogenados e utilização de pulverizador pressurizado por CO2. Em campo, foram aplicadas duas doses de glifosato (360 e 720 g ha-1), isoladas ou combinadas a duas concentrações de ureia (2,5 e 5,0 g L-1) ou sulfato de amônio (7,5 e 15,0 g L-1). Em laboratório, mensurou-se o pH de caldas de glifosato após o uso de diferentes concentrações do produto e dos fertilizantes nitrogenados e após a utilização do pulverizador pressurizado por CO2. Em todas as avaliações do experimento em campo, a menor dose de glifosato teve maior eficácia biológica após a adição de sulfato de amônio (15 g L-1) à calda. A ureia (5 g L-1) proporcionou efeitos benéficos somente na avaliação aos 28 dias após a aplicação. Em laboratório, o aumento da concentração de glifosato promoveu gradativa acidificação da calda de pulverização, com estabilização do pH da solução em 4,5. O sulfato de amônio causou pequena acidificação da calda herbicida, enquanto a ureia não alterou o pH. O uso do pulverizador pressurizado por CO2 pouco alterou o pH da calda de glifosato. A maior eficácia do glifosato após a adição de fertilizantes nitrogenados à calda está pouco relacionada com alterações no pH da solução.

Mobilization of hemopoietic stem cells with high-dose methotrexate plus granulocyte-colony-stimulating factor in patients with primary central nervous system lymphoma.

BACKGROUND: High-dose therapy with autologous stem cell support after standard dose induction is a promising approach for therapy of primary central nervous system lymphoma (PCNSL). High-dose methotrexate (HD-MTX) is a standard drug for induction of PCNSL; however, data about the capacity of HD-MTX plus granulocyte-colony-stimulating factor (G-CSF) to mobilize hemopoietic progenitors are lacking. STUDY DESIGN AND METHODS: This investigation describes the data from stem cell mobilization and apheresis procedures after one or two cycles of HD-MTX for induction of PCNSL within the East German Study Group for Haematology and Oncology 053 trial. Eligible patients proceeded to high-dose busulfan/thiotepa after induction therapy and mobilization. RESULTS: Data were available from nine patients with a median age of 58 years. The maximal CD34+ cell count per microL of blood after the first course of HD-MTX was 13.89 (median). Determination was repeated in six patients after the second course with a significantly higher median CD34+ cell count of 33.69 per microL. Five patients required two apheresis procedures and in four patients a single procedure was sufficient. The total yield of CD34+ cells per kg of body weight harvested by one or two leukapheresis procedures was 6.60 x 10(6) (median; range, 2.68 x 10(6)-15.80 x 10(6)). The yield of CD34+ cells exceeded the commonly accepted lower threshold of 3 x 10(6) cells per kg of body weight in eight of nine cases. Even in the ninth, hemopoietic recovery after stem cell reinfusion was rapid and safe. CONCLUSION: HD-MTX plus G-CSF is a powerful combination for stem cell mobilization in patients with PCNSL and permits safe conduction of time-condensed and dose-intense protocols with high-dose therapy followed by stem cell reinfusion after HD-MTX induction.

Método para monitoramento de ninfas de cigarras e controle com inseticidas em reflorestamentos com paricá

O objetivo deste trabalho foi estabelecer um método para o monitoramento da população de cigarras (Quesada gigas) e para a avaliação da eficácia de doses de thiamethoxam, carbofuran e imidaclopride no controle de ninfas, em reflorestamento com paricá (Schizolobium parahyba var. amazonicum). Foram utilizadas as seguintes dosagens de inseticidas: 2,0, 4,0 e 6,0 kg ha-1 do produto comercial Actara (250 WG), para o princípio ativo thiamethoxan; 7,15, 14,30, 21,45 L ha-1 de Furadan (350 FS), para o carbofuran; e 4,5, 9,0, 13,5 L ha-1 de Provado (200 SC), para o imidaclopride. As três dosagens de cada produto foram aplicadas em área total. Foram realizadas três avaliações quinzenais, posteriores à aplicação, em que foram contabilizados os números de buracos e de ninfas vivas, por meio da abertura, com implemento tratorizado, de trincheiras com 7 m de comprimento, 0,8 m de largura e 0,07 m de profundidade. Todos os princípios ativos testados foram eficientes na redução da população de ninfas de Q. gigas, mas não houve efeito significativo das doses avaliadas. Os princípios ativos carbofuran e thiamethoxan são os mais promissores, com controle de 75-80% da infestação de ninfas. A abertura de trincheiras com o implemento tratorizado é eficaz no monitoramento da população de ninfas de Q. gigas, em reflorestamentos com paricá.

Cell-permeable peptides induce dose- and length-dependent cytotoxic effects.

We have explored the threshold of tolerance of three unrelated cell types to treatments with potential cytoprotective peptides bound to Tat(48-57) and Antp(43-58) cell-permeable peptide carriers. Both Tat(48-57) and Antp(43-58) are well known for their good efficacy at crossing membranes of different cell types, their overall low toxicity, and their absence of leakage once internalised. Here, we show that concentrations of up to 100 microM of Tat(48-57) were essentially harmless in all cells tested, whereas Antp(43-58) was significantly more toxic. Moreover, all peptides bound to Tat(48-57) and Antp(43-58) triggered significant and length-dependent cytotoxicity when used at concentrations above 10 microM in all but one cell types (208F rat fibroblasts), irrespective of the sequence of the cargo. Absence of cytotoxicity in 208F fibroblasts correlated with poor intracellular peptide uptake, as monitored by confocal laser scanning fluorescence microscopy. Our data further suggest that the onset of cytotoxicity correlates with the activation of two intracellular stress signalling pathways, namely those involving JNK, and to a lesser extent p38 mitogen-activated protein kinases. These responses are of particular concern for cells that are especially sensitive to the activation of stress kinases. Collectively, these results indicate that in order to avoid unwanted and unspecific cytotoxicity, effector molecules bound to Tat(48-57) should be designed with the shortest possible sequence and the highest possible affinity for their binding partners or targets, so that concentrations below 10 microM can be successfully applied to cells without harm. Considering that cytotoxicity associated to Tat(48-57)- and Antp(43-58) bound peptide conjugates was not restricted to a particular type of cells, our data provide a general framework for the design of cell-penetrating peptides that may apply to broader uses of intracellular peptide and drug delivery.

Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct monte carlo methods.

Dose kernel convolution (DK) methods have been proposed to speed up absorbed dose calculations in molecular radionuclide therapy. Our aim was to evaluate the impact of tissue density heterogeneities (TDH) on dosimetry when using a DK method and to propose a simple density-correction method. METHODS: This study has been conducted on 3 clinical cases: case 1, non-Hodgkin lymphoma treated with (131)I-tositumomab; case 2, a neuroendocrine tumor treatment simulated with (177)Lu-peptides; and case 3, hepatocellular carcinoma treated with (90)Y-microspheres. Absorbed dose calculations were performed using a direct Monte Carlo approach accounting for TDH (3D-RD), and a DK approach (VoxelDose, or VD). For each individual voxel, the VD absorbed dose, D(VD), calculated assuming uniform density, was corrected for density, giving D(VDd). The average 3D-RD absorbed dose values, D(3DRD), were compared with D(VD) and D(VDd), using the relative difference Δ(VD/3DRD). At the voxel level, density-binned Δ(VD/3DRD) and Δ(VDd/3DRD) were plotted against ρ and fitted with a linear regression. RESULTS: The D(VD) calculations showed a good agreement with D(3DRD). Δ(VD/3DRD) was less than 3.5%, except for the tumor of case 1 (5.9%) and the renal cortex of case 2 (5.6%). At the voxel level, the Δ(VD/3DRD) range was 0%-14% for cases 1 and 2, and -3% to 7% for case 3. All 3 cases showed a linear relationship between voxel bin-averaged Δ(VD/3DRD) and density, ρ: case 1 (Δ = -0.56ρ + 0.62, R(2) = 0.93), case 2 (Δ = -0.91ρ + 0.96, R(2) = 0.99), and case 3 (Δ = -0.69ρ + 0.72, R(2) = 0.91). The density correction improved the agreement of the DK method with the Monte Carlo approach (Δ(VDd/3DRD) < 1.1%), but with a lesser extent for the tumor of case 1 (3.1%). At the voxel level, the Δ(VDd/3DRD) range decreased for the 3 clinical cases (case 1, -1% to 4%; case 2, -0.5% to 1.5%, and -1.5% to 2%). No more linear regression existed for cases 2 and 3, contrary to case 1 (Δ = 0.41ρ - 0.38, R(2) = 0.88) although the slope in case 1 was less pronounced. CONCLUSION: This study shows a small influence of TDH in the abdominal region for 3 representative clinical cases. A simple density-correction method was proposed and improved the comparison in the absorbed dose calculations when using our voxel S value implementation.

Produtividade, qualidade de tubérculos e incidência de doenças em batata, influenciados pela aplicação foliar de silício

O objetivo deste trabalho foi avaliar o efeito da aplicação de silício por via foliar, na forma de ácido silícico estabilizado, sobre a incidência de doenças, produtividade e qualidade de batata. Foram realizados três experimentos: um com a cultivar Agata e outro com a Atlantic, em Botucatu, SP; e um com a cultivar Agata, em Itaí, SP. Utilizou-se delineamento de blocos ao acaso, com oito repetições. Os tratamentos consistiram de: testemunha (sem aplicação de Si) e aplicação de Si via foliar, na dose 2 L ha-1, de produto comercial com 0,8% de Si solúvel como concentrado estabilizado de ácido silícico. A dose de Si foi parcelada em quatro aplicações durante o ciclo da cultura. A aplicação de Si reduz a severidade da requeima e a incidência de canela-preta, além de aumentar a produtividade e o teor de matéria seca dos tubérculos. O fornecimento de Si via foliar aumenta a produtividade de tubérculos, independentemente de seus efeitos sobre a incidência de doenças.

Amlodipine and valsartan as components of a rational and effective fixed-dose combination.

Pharmacological treatment of hypertension is effective in preventing cardiovascular and renal complications. Calcium antagonists and blockers of the renin-angiotensin system are widely used today to initiate antihypertensive therapy but, when given as monotherapy, do not suffice in most patients to normalize blood pressure. Combining the two types of agents considerably increases the antihypertensive efficacy, but not at the expense of a deterioration of tolerability. This is exemplified by the experience accumulated with the recently developed fixed dose combination containing the AT(1)-receptor blocker valsartan (160 mg) and the dihydropyridine amlodipine (5 or 10 mg). In a randomized trial, an 8-week treatment normalized blood pressure (<140/90 mmHg) within 8 weeks in a large fraction of hypertensive patients (78.4% and 85.2% using the 5/160 [n = 371] and 10/160 mg [n = 377] dosage, respectively). Like all AT(1)-receptor blockers valsartan has a placebo-like tolerability. Valsartan prevents to a large extent the occurrence amlodipine-induced peripheral edema. Both amlodipine and valsartan have beneficial effects on cardiovascular morbidity and mortality, as well as protective effects on renal function. The co-administration of these two agents is therefore very attractive, as it enables a rapid and sustained blood pressure control in hypertensive patients. The availability of a fixed-dose combination based on amlodipine and valsartan is expected therefore to facilitate the management of hypertension, to improve long-term adherence with antihypertensive therapy and, ultimately, to have a positive impact on cardiovascular and renal outcomes.

Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.

INTRODUCTION: To report acute and late toxicities in patients with intermediate- and high-risk prostate cancer treated with combined high-dose-rate brachytherapy (HDR-B) and intensity-modulated radiation therapy (IMRT). MATERIALS AND METHODS: From March 2003 to September 2005, 64 men were treated with a single implant HDR-B with 21 Gy given in three fractions, followed by 50 Gy IMRT along with organ tracking. Median age was 66.1 years, and risk of recurrence was intermediate in 47% of the patients or high in 53% of the patients. Androgen deprivation therapy was received by 69% of the patients. Toxicity was scored according to the CTCAE version 3.0. Median follow-up was 3.1 years. RESULTS: Acute grade 3 genitourinary (GU) toxicity was observed in 7.8% of the patients, and late grades 3 and 4 GU toxicity was observed in 10.9% and 1.6% of the patients. Acute grade 3 gastrointestinal (GI) toxicity was experienced by 1.6% of the patients, and late grade 3 GI toxicity was absent. The urethral V(120) (urethral volume receiving &gt; or =120% of the prescribed HDR-B dose) was associated with acute (P=.047) and late &gt; or = grade 2 GU toxicities (P=.049). CONCLUSIONS: Late grades 3 and 4GU toxicity occurred in 10.9% and 1.6% of the patients after HDR-B followed by IMRT in association with the irradiated urethral volume. The impact of V(120) on GU toxicity should be validated in further studies.